- Home
- SHEL vs ABT Comparison
SHEL vs ABT Comparison
Compare SHEL & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHEL
- ABT
- Stock Information
- Founded
- SHEL 1907
- ABT 1888
- Country
- SHEL United Kingdom
- ABT United States
- Employees
- SHEL N/A
- ABT N/A
- Industry
- SHEL Oil & Gas Production
- ABT Medical/Dental Instruments
- Sector
- SHEL Energy
- ABT Health Care
- Exchange
- SHEL Nasdaq
- ABT Nasdaq
- Market Cap
- SHEL 199.9B
- ABT 194.8B
- IPO Year
- SHEL N/A
- ABT N/A
- Fundamental
- Price
- SHEL $66.72
- ABT $113.45
- Analyst Decision
- SHEL Buy
- ABT Buy
- Analyst Count
- SHEL 6
- ABT 15
- Target Price
- SHEL $79.36
- ABT $129.80
- AVG Volume (30 Days)
- SHEL 4.0M
- ABT 5.0M
- Earning Date
- SHEL 01-30-2025
- ABT 01-22-2025
- Dividend Yield
- SHEL 4.13%
- ABT 2.08%
- EPS Growth
- SHEL N/A
- ABT 12.04
- EPS
- SHEL 2.42
- ABT 3.29
- Revenue
- SHEL $296,762,000,000.00
- ABT $41,217,000,000.00
- Revenue This Year
- SHEL N/A
- ABT $5.70
- Revenue Next Year
- SHEL N/A
- ABT $7.10
- P/E Ratio
- SHEL $13.27
- ABT $34.49
- Revenue Growth
- SHEL N/A
- ABT 3.15
- 52 Week Low
- SHEL $60.15
- ABT $99.71
- 52 Week High
- SHEL $74.61
- ABT $121.64
- Technical
- Relative Strength Index (RSI)
- SHEL 66.52
- ABT 48.55
- Support Level
- SHEL $63.81
- ABT $110.86
- Resistance Level
- SHEL $66.13
- ABT $113.81
- Average True Range (ATR)
- SHEL 0.73
- ABT 1.66
- MACD
- SHEL 0.49
- ABT 0.06
- Stochastic Oscillator
- SHEL 90.34
- ABT 50.88
About SHEL Shell PLC (each representing two (2))
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.5 million barrels of liquids and 7.3 billion cubic feet of natural gas per day. At end-2023, reserves stood at 9.6 billion barrels of oil equivalent, 49% of which, consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.6 mmb/d located in the Americas, Asia, Africa, and Europe and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.